Sjögren's disease trials in Israel

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

  Where

  Kfar Saba, Petah Tikva, Ramat Gan, Tel Aviv, Tsrifin

  Age

  18 years to 100 years

  People

  344 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07737743 · EU 2025-524513-92-00
• Phase 3Taking people
  A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

  Where

  Kafr Saba, Ramat Gan

  Age

  18 years and over

  People

  844 worldwide

  Run by

  Amgen

  See details and how to joinNCT06747949 · EU 2024-517513-32-00
• No phaseTaking people
  Meir Medical Center Rheumatologic Biobank

  Where

  Kfar Saba

  Age

  18 years to 120 years

  People

  500

  Run by

  Meir Medical Center

  See details and how to joinNCT03473912